Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance

QR Code

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance

Since 2010, Russia has been developing new drug legislation, internal quality control and safety of medical organizations, and has developed algorithms for submitting Individual Case Safety Reports (ICSR) using an automated information system. On April 1, 2019, Russia launched an updated national da...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Zhuravleva, B. K. Romanov, G. I. Gorodetskaya, O. V. Muslimova, V. S. Krysanova, E. Yu. Demchenkova
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	pharmacovigilance drug safety adverse reactions individual case safety report triggers to identify adverse reactions
Online Access:	https://www.risksafety.ru/jour/article/view/153
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving the Pharmacovigilance System in Medical Organisations as an Opportunity to Enhance the Quality of Pharmacotherapy
by: M. V. Zhuravleva, et al.
Published: (2025-04-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Role of Pharmacovigilance in Drug Safety Monitoring
by: Anju E. Paul, et al.
Published: (2025-07-01)

Analysis of Data on Adverse Drug Reactions and Functional Flaws of the Pharmacovigilance System Associated with Self-Treatment with Antibiotics
by: N. V. Verlan, et al.
Published: (2022-10-01)

Analysis of pharmacy organisation staff awareness of pharmacovigilance
by: R. I. Yagudina, et al.
Published: (2025-06-01)

SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?
by: A. S. Kolbin, et al.
Published: (2013-05-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Retrospective Analysis of Spontaneous Reports of Fatal Adverse Reactions Associated with Lidocaine
by: A. V. Matveev, et al.
Published: (2024-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
by: E. K. Nezhurina, et al.
Published: (2024-12-01)

Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model
by: T.Y. Sree Sudha, et al.
Published: (2025-12-01)

THE AGGREGATE APPROACH TO THE PERIODIZATION OF THE FORMATION OF THE PHARMACOVIGILANCE SYSTEM
by: A. Е. Krasheninnikov
Published: (2019-01-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

THE SYSTEM OF PHARMACOVIGILANCE AT A PHARMACEUTICAL PLANT
by: E. A. Sitnikova, et al.
Published: (2019-01-01)

DEBATABLE PROBLEMS OF PHARMACOVIGILANCE
by: Yu. V. Muravyev, et al.
Published: (2018-03-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

“Implementing the pharmacovigilance system and publishing this journal, we were helping healthcare providers cultivate the sense of professional and civic responsibility”
by: V. K. Lepakhin, et al.
Published: (2024-04-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU
by: G. N. Gildeeva, et al.
Published: (2019-07-01)

Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2022-08-01)

Learning Needs as a Reflection of Professional Interests among Health Experts
by: N. G. Goloenko, et al.
Published: (2019-03-01)

Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database
by: S. A. Mishinova, et al.
Published: (2024-04-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Safety of Biological Medicinal Products for Hereditary Coagulopathies: An Analysis of the Russian Pharmacovigilance Database
by: D. S. Fokina, et al.
Published: (2025-06-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
by: Ulrik Lausten-Thomsen, et al.
Published: (2025-06-01)

DARE-SAFE: Denominator-Adjusted Rate Estimates of Substance Adverse Events Frequency Evaluation in Pharmaceuticals and Vaccines
by: Matthew Halma, et al.
Published: (2025-03-01)

Literature Monitoring for Pharmacovigilance
by: A. G. Khudoshin, et al.
Published: (2019-03-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases
by: Yu. R. Bolsunovskaya, et al.
Published: (2022-12-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)